Advertisement

Topics

Megafusion - Bristol-Myers Squibb will Celgene kaufen

10:33 EST 3 Jan 2019 | FinanzNachrichten

Das ist ein verspäteter Silversterknaller. Bristol-Myers Squibb bietet 74 Milliarden USD für die Biotechfirma Celgene! Mit diesem Schritt könnte Bristol-Myers Squibb der führende Biopharma-Medikame...

Original Article: Megafusion - Bristol-Myers Squibb will Celgene kaufen

NEXT ARTICLE

More From BioPortfolio on "Megafusion - Bristol-Myers Squibb will Celgene kaufen"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...